BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $266,400 | -64.3% | 40,000 | 0.0% | 0.00% | -75.0% |
| Q1 2023 | $746,400 | -13.1% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $859,200 | +81.6% | 40,000 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $473,000 | -10.4% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $528,000 | -36.8% | 40,000 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $836,000 | +2.8% | 40,000 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $813,000 | -33.0% | 40,000 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $1,214,000 | +4.5% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,162,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |